About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 3

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

NCT05890001•Braintree Laboratories

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Non-erosive Reflux DiseaseErosive Esophagitis

Interventions

BLI5100

Locations

60

United States

Locations (60)

Research Site 24

Huntsville, Alabama, United States

Research Site 62

Phoenix, Arizona, United States

Research Site 27

Tucson, Arizona, United States

Research Site 87

Little Rock, Arkansas, United States

Research Site 117

North Little Rock, Arkansas, United States

Research Site 94

Chula Vista, California, United States

Key Dates

Start Date

April 5, 2023

Primary Completion Date

October 8, 2024

Completion Date

October 8, 2024

Last Updated

September 26, 2025

Related Studies

Not Yet RecruitingNA

Clinical Efficacy Evaluation of Chaizhi Hewei Decoction in the Treatment of Non-Erosive Reflux Disease With Liver-Stomach Disharmony Syndrome

NCT07518420

Non-erosive Reflux Disease (NERD)

COMPLETEDPhase 3

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

NCT05587309

Erosive Esophagitis

Evaluation of the Efficacy and Safety of Eolo in Patients With NERD

NCT07041060

Non-erosive Reflux DiseaseReflux Disease, Gastro-Esophageal+1 more

COMPLETEDPhase 3

A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients

NCT01499368

Erosive Esophagitis

COMPLETEDPhase 1

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008

NCT05050188

Erosive Esophagitis

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)

NCT06121830

Non-erosive Reflux DiseaseNon-Erosive Gastro-Esophageal Reflux Disease+1 more

View all related studies

Sponsors

Lead Sponsor

Braintree Laboratories

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 26, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions